Riley Antony A
CHIEF FINANCIAL OFFICER
Officer
Latest Insider Transactions
Showing 10 of 20 transactions (past 365 days)
| 2026-08-27 | 2026-08-27 | FBRX Forte Biosciences, Inc. | CFO | Disposition | 22,000 | $17.15 | $377,300 |
| 2026-08-27 | 2026-08-27 | FBRX Forte Biosciences, Inc. | CFO | Disposition | 323,000 | $7.54 | $2,435,420 |
| 2026-08-27 | 2026-08-27 | FBRX Forte Biosciences, Inc. | CFO | Disposition | 14,000 | $17.25 | $241,500 |
| 2026-08-27 | 2026-08-27 | FBRX Forte Biosciences, Inc. | CFO | Disposition | 90,000 | $29.66 | $2,669,400 |
| 2026-08-27 | 2026-08-27 | FBRX Forte Biosciences, Inc. | CFO | Disposition | 421 | $31.00 | $13,051 |
| 2026-08-27 | 2026-08-27 | FBRX Forte Biosciences, Inc. | CFO | Disposition | 2,999 | $43.00 | $128,957 |
| 2026-08-27 | 2026-08-27 | FBRX Forte Biosciences, Inc. | CFO | Disposition | 2,999 | $364.50 | $1,093,136 |
| 2026-08-27 | 2026-08-27 | FBRX Forte Biosciences, Inc. | CFO | Disposition | 1,700 | $991.50 | $1,685,550 |
| 2026-08-27 | 2026-08-27 | FBRX Forte Biosciences, Inc. | CFO | Tender Special | 42,600 | $0.00 | $0 |
| 2026-07-06 | 2026-07-01 | FBRX Forte Biosciences, Inc. | CFO | Exercise Conversion | 375 | $0.00 | $0 |
FBRX
CFO
Disposition
$377.3K
22,000 shares @ $17.15
Filed 2026-08-27Trade 2026-08-27
Forte Biosciences, Inc.FBRX
CFO
Disposition
$2.4M
323,000 shares @ $7.54
Filed 2026-08-27Trade 2026-08-27
Forte Biosciences, Inc.FBRX
CFO
Disposition
$241.5K
14,000 shares @ $17.25
Filed 2026-08-27Trade 2026-08-27
Forte Biosciences, Inc.FBRX
CFO
Disposition
$2.7M
90,000 shares @ $29.66
Filed 2026-08-27Trade 2026-08-27
Forte Biosciences, Inc.FBRX
CFO
Disposition
$1.1M
2,999 shares @ $364.50
Filed 2026-08-27Trade 2026-08-27
Forte Biosciences, Inc.FBRX
CFO
Disposition
$1.7M
1,700 shares @ $991.50
Filed 2026-08-27Trade 2026-08-27
Forte Biosciences, Inc.FBRX
CFO
Exercise Conversion
$0
375 shares @ $0.00
Filed 2026-07-06Trade 2026-07-01
Forte Biosciences, Inc.Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.